RFS
CPRX

Richardson Financial Services’s Catalyst Pharmaceutical CPRX Stock Holding History

Richardson Financial Services’s Portfolio CPRX Stock Details CPRX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		– Sell
-1,358
Closed -$33.6K – 619
2026
Q1 		$33.6K Buy
+1,358
New +$32.4K 0.02% 355
2025
Q3 		– Sell
-525
Closed -$11.1K – 530
2025
Q2 		$11.1K Buy
525
+91
+21% +$2.15K 0.01% 400
2025
Q1 		$10.5K Hold
434
– – 0.01% 376
2024
Q4 		$9.14K Buy
+434
New +$9.32K 0.01% 406
2024
Q1 		– Sell
-493
Closed -$8.29K – 627
2023
Q4 		$8.29K Buy
+493
New +$6.74K 0.01% 325

Other funds holding CPRX

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
American Century Companies
American Century Companies Kansas City, Missouri $226B AUM 44.75% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return
GCL
Glazer Capital LLC New York $4.07B AUM 78.71% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
HI
HBK Investments Dallas, Texas $10.2B AUM 67.73% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Richardson Financial Services's CPRX Position: Q2 2026 in Review

Richardson Financial Services sold out of Catalyst Pharmaceutical (CPRX) in Q2 2026, closing a stake of 1,358 shares — an estimated $33.6K sold.

Richardson Financial Services first reported a position in CPRX in Q4 2023 and held it in 5 quarters. The position peaked at $33.6K in Q1 2026. 396 funds tracked by Wall St. Rank hold CPRX as of Q2 2026.

  • Richardson Financial Services reported no remaining Catalyst Pharmaceutical position as of Q2 2026 after selling out during the quarter.
  • Richardson Financial Services sold 1,358 Catalyst Pharmaceutical shares in Q2 2026, an estimated $33.6K.
  • Richardson Financial Services first reported a position in Catalyst Pharmaceutical in Q4 2023 and held it in 5 quarters.
  • Richardson Financial Services's Catalyst Pharmaceutical position peaked at $33.6K in Q1 2026.
  • 396 funds tracked by Wall St. Rank held Catalyst Pharmaceutical as of Q2 2026.

Based on Richardson Financial Services's 13F filing for Q2 2026, filed 10 Aug 2026.